First Trust Nasdaq Pharmaceuticals ETF (FTXH)
NASDAQ: FTXH · Real-Time Price · USD
34.00
-0.59 (-1.71%)
At close: May 7, 2026, 4:00 PM EDT
34.00
0.00 (0.00%)
After-hours: May 7, 2026, 4:15 PM EDT
FTXH Holdings Information
FTXH is an equity ETF with a total of 51 individual holdings. The top holdings are Eli Lilly and Company stock at 7.18%, Merck & Co. at 6.98%, Bristol-Myers Squibb Company at 6.97%, Johnson & Johnson at 6.93%, and AbbVie at 6.78%.
Total Holdings
51
Top 10 Percentage
53.07%
Asset Class
Equity
ETF Category
Health
Assets
34.54M
PE Ratio
18.22
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 7.18% |
| 2 | MRK | Merck & Co., Inc. | 6.98% |
| 3 | BMY | Bristol-Myers Squibb Company | 6.97% |
| 4 | JNJ | Johnson & Johnson | 6.93% |
| 5 | ABBV | AbbVie Inc. | 6.78% |
| 6 | VTRS | Viatris Inc. | 3.97% |
| 7 | BIIB | Biogen Inc. | 3.76% |
| 8 | PFE | Pfizer Inc. | 3.65% |
| 9 | REGN | Regeneron Pharmaceuticals, Inc. | 3.43% |
| 10 | GILD | Gilead Sciences, Inc. | 3.42% |
| 11 | CAH | Cardinal Health, Inc. | 3.28% |
| 12 | ZTS | Zoetis Inc. | 3.28% |
| 13 | VRTX | Vertex Pharmaceuticals Incorporated | 3.26% |
| 14 | AMGN | Amgen Inc. | 3.24% |
| 15 | UTHR | United Therapeutics Corporation | 3.22% |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 2.45% |
| 17 | INCY | Incyte Corporation | 2.30% |
| 18 | ILMN | Illumina, Inc. | 1.76% |
| 19 | EXEL | Exelixis, Inc. | 1.58% |
| 20 | CRL | Charles River Laboratories International, Inc. | 1.36% |
| 21 | MEDP | Medpace Holdings, Inc. | 1.29% |
| 22 | NBIX | Neurocrine Biosciences, Inc. | 1.23% |
| 23 | PTCT | PTC Therapeutics, Inc. | 1.22% |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 1.16% |
| 25 | HALO | Halozyme Therapeutics, Inc. | 1.14% |
As of May 5, 2026